DrFirst, Inc.

drfirst.com

DrFirst, Inc.
Since 2000, DrFirst has pioneered healthcare technology solutions and consulting services that securely connect people at touchpoints of care to improve patient outcomes. We create unconventional solutions that solve care collaboration, medication management, price transparency, and adherence challenges in healthcare. We unite the Healthiverse™ by providing our clients with real-time access to the information they need, exactly when and how they need it – so patients get the best care possible.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HEALTH TECHNOLOGY

MEDNOW ENTERS INTO AGREEMENT TO ACQUIRE MEDNOW EAST INC IN ONTARIO

Mednow Inc. | March 08, 2022

news image

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has entered into a share purchase agreement on March 4, 2021 with Mednow East Inc.and the shareholders of Mednow East, pursuant to which the Company shall acquire all of the issued and outstanding shares of Mednow East, in consideration for an aggregate cash payment of approximately C$65,578 and the Company’s agreement to convert approximately C$1,374,422 owed by Mednow East to the...

Read More

HEALTH TECHNOLOGY

FDA-APPROVED INVESTIGATOR-INITIATED PRE-MARKET CLINICAL TRIAL OF LAMBRE™ PLUS LAA CLOSURE SYSTEM OBTAINED MEDICAL INSURANCE COVERAGE IN THE US

LifeTech Scientific Corporation | September 06, 2022

news image

LifeTech Scientific Corporation is pleased to announce that on 30 August 2022, an FDA-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre™ Plus Left Atrial Appendage (LAA) Closure System has obtained medical insurance coverage in the United States, meaning that all patient enrollment of the clinical trial will be fully covered by the USA medical insurance. This is expected to facilitate the marketing and registration process of the innovative device in th...

Read More

HEALTH TECHNOLOGY

L2MTECH GMBH RECEIVES CE MARK APPROVAL ON 6(SIX) PRODUCTS FOR CARDIOVASCULAR AND ENDOVASCULAR APPLICATIONS

L2Mtech | February 17, 2021

news image

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent S...

Read More

CVS PLEDGES $1M TO MENTAL HEALTH SUPPORTS FOR FRONTLINE WORKERS; TRUMP SAYS COVID-19 VACCINE WILL BE READY BY YEAR-END

CVS | May 04, 2020

news image

CVS pledges $1 million to boost mental health supports CVS Health said it would put more than $1 million toward boosting access mental health services for frontline workers effected by COVID-19. The healthcare giant called the growing need for mental health services a "second curve" to the pandemic. CVS said it has seen a 200% increase year over year in virtual mental health visits since March 1. The Aetna Foundation will provide $500,000 to Americares for its COVI...

Read More
news image

HEALTH TECHNOLOGY

MEDNOW ENTERS INTO AGREEMENT TO ACQUIRE MEDNOW EAST INC IN ONTARIO

Mednow Inc. | March 08, 2022

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has entered into a share purchase agreement on March 4, 2021 with Mednow East Inc.and the shareholders of Mednow East, pursuant to which the Company shall acquire all of the issued and outstanding shares of Mednow East, in consideration for an aggregate cash payment of approximately C$65,578 and the Company’s agreement to convert approximately C$1,374,422 owed by Mednow East to the...

Read More
news image

HEALTH TECHNOLOGY

FDA-APPROVED INVESTIGATOR-INITIATED PRE-MARKET CLINICAL TRIAL OF LAMBRE™ PLUS LAA CLOSURE SYSTEM OBTAINED MEDICAL INSURANCE COVERAGE IN THE US

LifeTech Scientific Corporation | September 06, 2022

LifeTech Scientific Corporation is pleased to announce that on 30 August 2022, an FDA-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre™ Plus Left Atrial Appendage (LAA) Closure System has obtained medical insurance coverage in the United States, meaning that all patient enrollment of the clinical trial will be fully covered by the USA medical insurance. This is expected to facilitate the marketing and registration process of the innovative device in th...

Read More
news image

HEALTH TECHNOLOGY

L2MTECH GMBH RECEIVES CE MARK APPROVAL ON 6(SIX) PRODUCTS FOR CARDIOVASCULAR AND ENDOVASCULAR APPLICATIONS

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent S...

Read More
news image

CVS PLEDGES $1M TO MENTAL HEALTH SUPPORTS FOR FRONTLINE WORKERS; TRUMP SAYS COVID-19 VACCINE WILL BE READY BY YEAR-END

CVS | May 04, 2020

CVS pledges $1 million to boost mental health supports CVS Health said it would put more than $1 million toward boosting access mental health services for frontline workers effected by COVID-19. The healthcare giant called the growing need for mental health services a "second curve" to the pandemic. CVS said it has seen a 200% increase year over year in virtual mental health visits since March 1. The Aetna Foundation will provide $500,000 to Americares for its COVI...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us